<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
<meta http-equiv="Content-Type" content=
"text/html; charset=utf-8" /><!-- AppResources meta begin -->

<script type="text/javascript">
//<![CDATA[
var ncbi_startTime = new Date();
//]]>
</script><!-- AppResources meta end -->
<!-- TemplateResources meta begin -->
<meta name="paf_template" content="" />
<!-- TemplateResources meta end -->
<!-- Logger begin -->
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_pdid" content="article" />
<meta name="ncbi_acc" content="" />
<meta name="ncbi_domain" content="brjclinpharm" />
<meta name="ncbi_report" content="record" />
<meta name="ncbi_type" content="fulltext" />
<meta name="ncbi_objectid" content="" />
<meta name="ncbi_pcid" content="/articles/PMC2015049/" />
<meta name="ncbi_app" content="pmc" /><!-- Logger end -->
<title>The pharmacokinetics of ziprasidone in healthy volunteers
treated with cimetidine or antacid</title>
<!-- AppResources external_resources begin -->
<link rel="stylesheet" href="/core/jig/1.14.4/css/jig.min.css" />
<script type="text/javascript" src=
"/core/jig/1.14.4/js/jig.min.js">
</script><!-- AppResources external_resources end -->
<!-- Page meta begin -->
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" />
<link rel="canonical" href="/pmc/articles/PMC2015049/" />
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" />
<meta name="citation_journal_title" content=
"British Journal of Clinical Pharmacology" />
<meta name="citation_title" content=
"The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid" />
<meta name="citation_authors" content=
"K D Wilner, R A Hansen, C J Folger, P Geoffroy" />
<meta name="citation_date" content="January 2000" />
<meta name="citation_issue" content="Suppl 1" />
<meta name="citation_volume" content="49" />
<meta name="citation_firstpage" content="57S" />
<meta name="citation_doi" content=
"10.1046/j.1365-2125.2000.00154.x" />
<meta name="citation_abstract_html_url" content=
"/pmc/articles/PMC2015049/?report=abstract" />
<meta name="citation_pmid" content="10771455" />
<meta name="DC.Title" content=
"The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid" />
<meta name="DC.Type" content="Text" />
<meta name="DC.Publisher" content="Wiley-Blackwell" />
<meta name="DC.Contributor" content="K D Wilner" />
<meta name="DC.Contributor" content="R A Hansen" />
<meta name="DC.Contributor" content="C J Folger" />
<meta name="DC.Contributor" content="P Geoffroy" />
<meta name="DC.Date" content="2000 Jan" />
<meta name="DC.Identifier" content=
"10.1046/j.1365-2125.2000.00154.x" />
<meta name="DC.Language" content="en" />
<meta property="og:title" content=
"The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid" />
<meta property="og:type" content="article" />
<meta property="og:description" content=
"To evaluate the effects of cimetidine and Maalox® (aluminium hydroxide 1.35 g and magnesium hydroxide 1.2 g) on the pharmacokinetics of ziprasidone.Eleven healthy young subjects aged 18–45 years were given single oral doses of ziprasidone ..." />
<meta property="og:url" content=
"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2015049/" />
<meta property="og:site_name" content="PubMed Central (PMC)" />
<meta property="og:image" content=
"http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:site" content="@ncbi" />
<link rel="stylesheet" href="/corehtml/pmc/css/3.4/pmc.min.css"
type="text/css" />
<link rel="stylesheet" href=
"/corehtml/pmc/css/3.4/pmc_extras_prnt.min.css" type="text/css"
media="print" />
<script type="text/javascript" src=
"/corehtml/pmc/js/common.min.js">
//<![CDATA[
//
//]]>
</script>
<script type="text/javascript" src=
"/corehtml/pmc/js/NcbiTagServer.min.js">
//<![CDATA[
//
//]]>
</script>
<meta name="citationexporter" content=
"backend:'/pmc/utils/ctxp/'" />
<script type="text/javascript" src=
"/corehtml/pmc/ctxp/jquery.citationexporter.js">
//<![CDATA[
//
//]]>
</script>
<link rel="stylesheet" href=
"/corehtml/pmc/ctxp/citationexporter.css" type="text/css" />
<script type="text/javascript" src=
"/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js">
</script>
<script type="text/javascript" src=
"/corehtml/pmc/js/large-obj-scrollbars.min.js">
</script>
<script type="text/javascript">
//<![CDATA[
window.name="mainwindow";
//]]>
</script>
<style type="text/css">
/*<![CDATA[*/
.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-brjclinpharm.gif);background-size: auto, contain}
/*]]>*/
</style>

<style type="text/css">
/*<![CDATA[*/
.print-view{display:block}
/*]]>*/
</style>

<style type="text/css">
/*<![CDATA[*/
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
/*]]>*/
</style>
<link rel="alternate" type="application/epub+zip" href=
"/pmc/articles/PMC2015049/epub/" />
<link rel="alternate" type="application/pdf" href=
"/pmc/articles/PMC2015049/pdf/bcp0049-057S.pdf" />
<!-- Page meta end -->
<link rel="shortcut icon" href=
"//www.ncbi.nlm.nih.gov/favicon.ico" />
<meta name="ncbi_phid" content=
"F4FB67056FE7CA310000000000A5DF9B" />
<link type="text/css" rel="stylesheet" href=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/css/3852956/3985586/3808861/3734262/3974050/3917732/251717/4048120/3846471/14534/45193/3988413/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4052581/9685/3549676/3609192/3609193/3609213/3395586/3855312.css" />
<link type="text/css" rel="stylesheet" href=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/css/3411343/3882866/3929378.css"
media="print" />
</head>
<body class="article">
<div class="grid">
<div class="col twelve_col nomargin shadow">
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
<div class="sysmessages"><noscript>
<p class="nojs"><strong>Warning:</strong> The NCBI web site
requires JavaScript to function. <a href=
"/guide/browsers/#enablejs" title="Learn how to enable JavaScript"
target="_blank">more...</a></p>
</noscript></div>
<!--/.sysmessage-->
<div class="wrap">
<div class="page">
<div class="top">
<div class="universal_header" id="universal_header">
<ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id=
"navcontent">
<li class=
"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt">
<a class="ui-ncbimenu-link-first" href="/" role="banner" title=
"NCBI Home" id="ncbihome" accesskey="1"><span class=
"offscreen_noflow">NCBI</span><img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/28977"
class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href=
"#maincontent" title="Skip to the content" tabindex="0" accesskey=
"3">Skip to main content</a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href=
"#navcontent" title="Skip to the navigation" tabindex="0"
accesskey="4">Skip to navigation</a></li>
<li id="resource-menu" class=
"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset">
<a class=
"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown"
href=
"/static/header_footer_ajax/submenu/#resources">Resources</a></li>
<li id="all-howtos-menu" class=
"topmenu ui-helper-reset ui-ncbimenu-item-first"><a class=
"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown"
href="/static/header_footer_ajax/submenu/#howto">How To</a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href=
"/guide/browsers/#accesskeys" title="About My NCBI Accesskeys"
tabindex="0" accesskey="0">About NCBI Accesskeys</a></li>
</ul>
<div class="myncbi"><span id="myncbiusername" style=
"display:none"><a href="/account/settings/" id="mnu" title=
"Edit account settings"></a></span><a accesskey="2" href="/myncbi/"
id="myncbi" style="display:none">My NCBI</a><a href="/account/" id=
"sign_in">Sign in to NCBI</a><a href="/account/signout/" id=
"sign_out" style="display:none">Sign Out</a></div>
</div>
<div class="header">
<div class="res_logo">
<h1 class="img_logo"><a href="/pmc/" class=
"pmc_logo offscreen">PMC</a></h1>
<div class="NLMLogo"><a href="http://www.nlm.nih.gov/" title=
"US National Library of Medicine">US National Library of
Medicine</a><br />
<a href="http://www.nih.gov/" title=
"National Institutes of Health">National Institutes of
Health</a></div>
</div>
<div class="search">
<form method="get" action="/pmc/">
<div class="search_form"><label for="database" class=
"offscreen_noflow">Search database</label><select id="database">
<optgroup label="Recent">
<option value="pmc" selected="selected" class="last" data-ac_dict=
"pmc-search-autocomplete">PMC</option>
</optgroup>
<optgroup label="All">
<option value="gquery">All Databases</option>
<option value="assembly">Assembly</option>
<option value="bioproject">BioProject</option>
<option value="biosample">BioSample</option>
<option value="biosystems">BioSystems</option>
<option value="books">Books</option>
<option value="clinvar">ClinVar</option>
<option value="clone">Clone</option>
<option value="cdd">Conserved Domains</option>
<option value="gap">dbGaP</option>
<option value="dbvar">dbVar</option>
<option value="epigenomics">Epigenomics</option>
<option value="nucest">EST</option>
<option value="gene">Gene</option>
<option value="genome">Genome</option>
<option value="gds">GEO DataSets</option>
<option value="geoprofiles">GEO Profiles</option>
<option value="nucgss">GSS</option>
<option value="gtr">GTR</option>
<option value="homologene">HomoloGene</option>
<option value="medgen">MedGen</option>
<option value="mesh">MeSH</option>
<option value="ncbisearch">NCBI Web Site</option>
<option value="nlmcatalog">NLM Catalog</option>
<option value="nuccore">Nucleotide</option>
<option value="omim">OMIM</option>
<option value="pmc" data-ac_dict="pmc-search-autocomplete">
PMC</option>
<option value="popset">PopSet</option>
<option value="probe">Probe</option>
<option value="protein">Protein</option>
<option value="proteinclusters">Protein Clusters</option>
<option value="pcassay">PubChem BioAssay</option>
<option value="pccompound">PubChem Compound</option>
<option value="pcsubstance">PubChem Substance</option>
<option value="pubmed">PubMed</option>
<option value="pubmedhealth">PubMed Health</option>
<option value="snp">SNP</option>
<option value="sra">SRA</option>
<option value="structure">Structure</option>
<option value="taxonomy">Taxonomy</option>
<option value="toolkit">ToolKit</option>
<option value="toolkitall">ToolKitAll</option>
<option value="toolkitbook">ToolKitBook</option>
<option value="toolkitbookgh">ToolKitBookgh</option>
<option value="unigene">UniGene</option>
</optgroup>
</select>
<div class="nowrap"><label for="term" class="offscreen_noflow"
accesskey="/">Search term</label>
<div class="nowrap"><input type="text" name="term" id="term" title=
"Search PMC. Use up and down arrows to choose an item from the autocomplete."
value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config=
"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'"
autocomplete="off" data-sbconfig=
"ds:'no',pjs:'no',afs:'yes'" /></div>
<button id="search" type="submit" class="button_search nowrap" cmd=
"go">Search</button></div>
</div>
</form>
<ul class="searchlinks inline_list">
<li><a href="/pmc/limits/">Limits</a></li>
<li><a href="/pmc/advanced/">Advanced</a></li>
<li><a href="/pmc/journals/">Journal list</a></li>
<li class="help"><a target="_blank" href=
"/books/NBK3825/">Help</a></li>
</ul>
</div>
</div>
<!--<component id="Page" label="headcontent"/>--></div>
<div class="content"><!-- site messages -->
<div class="container">
<div id="maincontent" class="content eight_col col">
<div class="navlink-box">
<ul class="page-breadcrumbs inline_list small">
<li class="journal-list"><a href="/pmc/journals/" class=
"navlink">Journal List</a></li>
<li class="archive-page"><a class="navlink" href=
"/pmc/journals/279/">Br J Clin Pharmacol</a></li>
<li class="issue-page"><a class="navlink" href=
"/pmc/issues/151586/">v.49(Suppl 1); 2000 Jan</a></li>
<li class="accid">PMC2015049</li>
</ul>
</div>
<!-- Journal banner -->
<div class="pmc-page-banner whole_rhythm">
<div><img src="/corehtml/pmc/pmcgifs/logo-brjclinpharm.gif" alt=
"Logo of brjclinpharm" usemap="#logo-imagemap" /><map id=
"logo-imagemap" name="logo-imagemap">
<area alt="Link to Publisher's site" title=
"Link to Publisher's site" shape="default" coords="0,0,499,74"
href="http://www.blackwellpublishing.com/journal.asp?ref=0306-5251"
target="pmc_ext" ref=
"reftype=publisher&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" />
</map></div>
</div>
<!--component id='MainPortlet' label='search-reference'/-->
<!-- Book content -->
<div class="">
<div class=
"hide-overflow article lit-style content pmc-wm slang-all page-box">
<!--main-content-->
<div class="jig-ncbiinpagenav" data-jigconfig=
"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'">
<div class="fm-sec half_rhythm no_top_margin">
<div class="fm-citation half_rhythm no_top_margin clearfix">
<div class="small">
<div class="inline_block eight_col va_top">
<div>
<div><span class="cit">Br J Clin Pharmacol. 2000 Jan; 49(Suppl 1):
57S–60S.</span></div>
<div><span class="doi">doi:&nbsp; <a href=
"http://dx.doi.org/10.1046%2Fj.1365-2125.2000.00154.x" target=
"pmc_ext" ref=
"reftype=other&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">
10.1046/j.1365-2125.2000.00154.x</a></span></div>
</div>
</div>
<div class=
"inline_block four_col va_top show-overflow align_right">
<div class="fm-citation-ids">
<div class="fm-citation-pmcid"><span class=
"fm-citation-ids-label">PMCID:</span> <span>PMC2015049</span></div>
</div>
</div>
</div>
</div>
<h1 class="content-title">The pharmacokinetics of ziprasidone in
healthy volunteers treated with cimetidine or antacid</h1>
<div class="half_rhythm">
<div class="contrib-group fm-author"><a href=
"/pubmed/?term=Wilner%20KD%5Bauth%5D">K D Wilner</a>,<sup>1</sup>
<a href="/pubmed/?term=Hansen%20RA%5Bauth%5D">R A
Hansen</a>,<sup>1</sup> <a href=
"/pubmed/?term=Folger%20CJ%5Bauth%5D">C J Folger</a>,<sup>1</sup>
and <a href="/pubmed/?term=Geoffroy%20P%5Bauth%5D">P
Geoffroy</a><sup>2</sup></div>
</div>
<div class="fm-panel small half_rhythm">
<div class="fm-authors-info fm-panel hide half_rhythm" id=
"id1080716_ai" style="display:none">
<div class="fm-affl" lang="en"><sup>1</sup>Department of Clinical
Research, Pfizer Central Research, Groton, CT 06340, USA</div>
<div class="fm-affl" lang="en"><sup>2</sup>Phoenix International
Life Sciences Inc., St-Laurent, Quebec, Canada</div>
<div id="cor1"><em>Correspondence:</em> Dr K. D. Wilner, Department
of Clinical Pharmacology, Pfizer Central Research, Groton, CT
06340, USA.</div>
</div>
<div class="togglers"><a href="#" class="pmctoggle" rid=
"id1080716_ai">Author information <span>►</span></a> <a href="#"
class="pmctoggle" rid="id1080716_cpl">Copyright and License
information <span>►</span></a></div>
<div class="fm-article-notes fm-panel half_rhythm"></div>
<div class="fm-cpl-info fm-panel hide half_rhythm" id=
"id1080716_cpl" style="display:none">
<div class="fm-copyright half_rhythm"><a href=
"/pmc/about/copyright.html">Copyright</a> © 2000 Blackwell Science
Ltd</div>
</div>
</div>
<div class="links-box fm-panel whole_rhythm">
<div class="small">
<div>This article has been <a href=
"/pmc/articles/PMC2015049/citedby/">cited by</a> other articles in
PMC.</div>
</div>
</div>
</div>
<div class="sec"></div>
<div id="__abstractid1076241" lang="en" class="tsec sec">
<h2 class="head no_bottom_margin" id="__abstractid1076241title">
Abstract</h2>
<!--article-meta-->
<div>
<div id="__sec1" class="sec sec-first">
<h3>Aims</h3>
<p id="__p1" class="p p-first-last">To evaluate the effects of
cimetidine and Maalox® (aluminium hydroxide 1.35 g and magnesium
hydroxide 1.2 g) on the pharmacokinetics of ziprasidone.</p>
</div>
<div id="__sec2" class="sec">
<h3>Methods</h3>
<p id="__p2" class="p p-first-last">Eleven healthy young subjects
aged 18–45 years were given single oral doses of ziprasidone 40 mg
on three occasions at least 7 days apart. On one occasion
ziprasidone was administered alone, on another occasion ziprasidone
was co-administered with oral cimetidine 800 mg and on a third
occasion ziprasidone was co-administered with oral Maalox®.</p>
</div>
<div id="__sec3" class="sec">
<h3>Results</h3>
<p id="__p3" class="p p-first-last">The administration of
cimetidine increased the ziprasidone AUC(0, ∞) by 6% but there were
no statistically significant differences in
<em>C</em><sub>max</sub>, <em>t</em><sub>max</sub> or λ<sub>z</sub>
between the ziprasidone + cimetidine group and the ziprasidone
group. The administration of Maalox® did not produce any
statistically significant differences in AUC(0, ∞),
<em>C</em><sub>max</sub>, <em>t</em><sub>max</sub> or λ<sub>z</sub>
between the ziprasidone + Maalox® group and the ziprasidone
group.</p>
</div>
<div id="__sec4" class="sec sec-last">
<h3>Conclusions</h3>
<p id="__p4" class="p p-first-last">The pharmacokinetics of
ziprasidone are not affected by concurrent administration of
cimetidine or Maalox®. This suggests that other nonspecific
inhibitors of cytochrome P450 and antacids are unlikely to alter
the pharmacokinetics of ziprasidone.</p>
</div>
</div>
<div class="sec"><strong class="kwd-title">Keywords:</strong>
<span class="kwd-text">ziprasidone, aluminium, cimetidine,
interaction, magnesium, pharmacokinetics</span></div>
</div>
<div id="__sec5" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec5title">
Introduction</h2>
<p id="__p5" class="p p-first">Ziprasidone has a pharmacokinetic
profile unaffected by age and gender [<a href="#b1" rid="b1" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012241">1</a>]. It is extensively metabolized to inactive
derivatives in humans, and <em>in vitro</em> studies using human
liver microsomes have shown that the oxidative metabolism of
ziprasidone is primarily mediated by the 3A4 isoform of cytochrome
P450 (CYP3A4) [<a href="#b2" rid="b2" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012239">2</a>]. The absorption of orally administered
ziprasidone is enhanced when it is taken immediately after eating,
perhaps as a consequence of improved drug solubilization in the
presence of food [<a href="#b3" rid="b3" class=
" bibr popnode">3</a>].</p>
<p id="__p6">Cimetidine is an H<sub>2</sub> receptor antagonist
which is commonly used to treat duodenal ulcers, benign gastric
ulcers and hypersecretory states. It inhibits several isoforms of
cytochrome P450, including CYP3A4 [<a href="#b4" rid="b4" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012238">4</a>]. This inhibition can result in alterations
in the elimination of co-administered drugs which are also
oxidatively metabolized by CYP3A4. In addition, cimetidine can
alter gastric pH and therefore has the potential to affect the
absorption of co-administered drugs.</p>
<p id="__p7">Antacids are commonly used in the symptomatic relief
of dyspeptic symptoms and, usually in combination with
H<sub>2</sub> receptor antagonists, in the treatment of duodenal
ulcers. As they function by raising gastric pH, they have the
potential to affect the absorption of co-administered drugs.
Furthermore, they can influence the pharmacokinetics of
co-administered drugs through absorption or chelation.</p>
<p id="__p8" class="p p-last">This study was designed to determine
whether or not multiple-dose cimetidine or antacid administration
alters the pharmacokinetics of ziprasidone.</p>
</div>
<div id="__sec6" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec6title">Methods</h2>
<div id="__sec7" class="sec sec-first">
<h3>Subjects</h3>
<p id="__p9" class="p p-first-last">The subjects were healthy,
young (18–45 years) adults of either gender. All subjects weighed
≤91 kg and were within 10% of their ideal body weight for age,
height, sex and frame [<a href="#b5" rid="b5" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012237">5</a>]. None was pregnant or lactating and none
was a smoker. All subjects provided written informed consent.</p>
</div>
<div id="__sec8" class="sec">
<h3>Protocol</h3>
<p id="__p10" class="p p-first">This was an open-label, randomized,
three-way crossover study designed to determine whether multiple
doses of cimetidine and Maalox® alter the pharmacokinetics of
ziprasidone. The study protocol was approved by an independent
institutional review board.</p>
<p id="__p11">The study comprised three 1 day treatment periods
separated by intervals of at least 7 days. During each treatment
period each subject received one of three different treatments in
one of six sequences according to a computer-generated
randomization. These three treatments were: ziprasidone 40 mg
alone; ziprasidone 40 mg + cimetidine 800 mg; and ziprasidone 40 mg
+ Maalox® 30 ml (aluminium hydroxide 1.35 g and magnesium hydroxide
1.2 g).</p>
<p id="__p12" class="p p-last">Ziprasidone hydrochloride capsules
were administered orally, after a standard breakfast at
approximately 09.00 h. Cimetidine tablets were administered once
daily, at approximately 07.00h, commencing 2 days before
ziprasidone administration and continuing until 1 day after
ziprasidone dosing. Maalox® suspension was administered on the
evening before the administration of ziprasidone (approximately
23.00 h), immediately before the ziprasidone dosing (approximately
09.00 h), and after lunch (approximately 13.00 h) and dinner
(approximately 18.00 h) on the day that ziprasidone was taken.</p>
</div>
<div id="__sec9" class="sec">
<h3>Pharmacokinetic sampling</h3>
<p id="__p13" class="p p-first-last">Blood samples for the
determination of serum ziprasidone concentrations were collected
immediately before dosing and at fixed intervals up to 36 h after
each dose of ziprasidone.</p>
</div>
<div id="__sec10" class="sec">
<h3>Pharmacokinetic analysis</h3>
<p id="__p14" class="p p-first">Serum concentrations of ziprasidone
were determined using high performance liquid chromatography
involving solid-phase extraction and u.v. detection. The assay had
a dynamic range of 1.0–250.0 ng ml<sup>−1</sup>[<a href="#b6" rid=
"b6" class=" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012243">6</a>]. Ziprasidone concentrations below the
lower limit of quantification were assigned a value of 0 ng
ml<sup>−1</sup> in pharmacokinetic calculations.</p>
<p id="__p15" class="p p-last">The maximum serum concentration of
ziprasidone (<em>C</em><sub>max</sub>) and the earliest time at
which <em>C</em><sub>max</sub> occurred (<em>t</em><sub>max</sub>)
were estimated directly from the experimental data. The terminal
elimination rate constant for ziprasidone (λ<sub>z</sub>) was
estimated using least-squares regression analysis of the
ziprasidone concentration–time data obtained during the terminal
log-linear phase. The terminal half-life of ziprasidone
(<em>t</em><sub>½,z</sub>) was calculated as ln 2/λ<sub>z</sub>,
and the mean half-life of ziprasidone was estimated as ln 2/mean
λ<sub>z</sub>. The area under the serum concentration–time curve
from time zero to the last time (<em>t</em>) serum ziprasidone was
measurable (AUC(0, <em>t</em>)) was estimated by the linear
trapezoidal approximation. The area under the serum
concentration–time curve from the time <em>t</em> to infinity
(AUC(<em>t</em>, ∞)) was calculated as
<em>Cp</em><sub>est</sub>/λ<sub>z</sub>, where
<em>Cp</em><sub>est</sub> is the estimated concentration at the
last time serum ziprasidone was measurable based on the regression
analysis of the terminal log-linear phase. The total area under the
serum concentration–time curve (AUC(0, ∞)) was estimated as the sum
of the AUC(0, <em>t</em>) and AUC(<em>t</em>, ∞) values.</p>
</div>
<div id="__sec11" class="sec sec-last">
<h3>Statistical analysis</h3>
<p id="__p16" class="p p-first">Natural log-transformed AUC(0, ∞)
and <em>C</em><sub>max</sub> values, and untransformed
<em>t</em><sub>max</sub> and λ<sub>z</sub> values, were analysed in
a two-way analysis of variance (<span class=
"small-caps">anova</span>) model containing sequence, subject
within sequence, period and treatment effects (PROC GLM of SAS®).
The sequence effect was tested using the subject within sequence
mean square as the error term and the period effect was tested
using the within subject mean square error as the error term.</p>
<p id="__p17">Geometric means and standard deviations were
calculated for AUC(0, ∞) and <em>C</em><sub>max</sub>. Arithmetic
means and standard deviations were calculated for
<em>t</em><sub>max</sub> and λ<sub>z</sub>. Adjusted means, and
their variances and covariances, were then calculated using the
least-squares means statement from SAS®. These were then used to
estimate the difference between the treatment effects.</p>
<p id="__p18" class="p p-last">Student’s <em>t</em>-tests with 95%
confidence limits were used to examine pair-wise differences
between the groups. Values of <em>P</em>&lt; 0.05 were considered
to be statistically significant.</p>
</div>
</div>
<div id="__sec12" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec12title">Results</h2>
<div id="__sec13" class="sec sec-first">
<h3>Subjects</h3>
<p id="__p19" class="p p-first">Twelve subjects entered the study
(<a href="/pmc/articles/PMC2015049/table/tbl1/" target="true"
class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob=
"ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). Ten completed
all three treatment periods and were included in the
pharmacokinetic analysis (<em>n</em> = 10 for all three treatment
periods).</p>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl1"><a href="/pmc/articles/PMC2015049/table/tbl1/" target=
"table" rid-ob="ob-tbl1" rid-figpopup="tbl1" class=
"table img_link icnblk_img figpopup"><img alt="Table 1" title=
"Table 1" class="small-thumb" src=
"/pmc/articles/PMC2015049/table/tbl1/?report=thumb" src-large=
"/pmc/articles/PMC2015049/table/tbl1/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015049/table/tbl1/" target="table" rid-figpopup=
"tbl1" rid-ob="ob-tbl1">Table 1</a></div>
<!--caption a4-->
<div><span>Demographic characteristics.</span></div>
</div>
</div>
<p id="__p21" class="p p-last">One subject discontinued the study
after experiencing adverse events and only completed the
ziprasidone treatment period. Another subject discontinued the
study for personal reasons after completing the ziprasidone +
Maalox® and ziprasidone + cimetidine treatment periods.</p>
</div>
<div id="__sec14" class="sec sec-last">
<h3>Pharmacokinetics</h3>
<p id="__p22" class="p p-first">The mean serum ziprasidone
concentration–time curves for the three treatment groups were
broadly similar, but suggested a small but not statistically
significant delay in the occurrence of <em>C</em><sub>max</sub> in
the ziprasidone + Maalox® group compared with the ziprasidone alone
group (mean ratio 108.4%; 95% CI: 82.8,134) (<a href=
"/pmc/articles/PMC2015049/figure/fig01/" target="figure" class=
"fig-table-link fig figpopup" rid-figpopup="fig01" rid-ob=
"ob-fig01" co-legend-rid="lgnd_fig01"><span>Figure
1</span></a>).</p>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig01"
co-legend-rid="lgnd_fig01"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015049/figure/fig01/" target="figure"
rid-figpopup="fig01" rid-ob="ob-fig01"><img src=
"/pmc/articles/PMC2015049/bin/bcp0049-057S-f1.gif" class=
"small-thumb" alt="Figure 1" title="Figure 1" src-large=
"/pmc/articles/PMC2015049/bin/bcp0049-057S-f1.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig01">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015049/figure/fig01/" target="figure"
rid-figpopup="fig01" rid-ob="ob-fig01">Figure 1</a></div>
<!--caption a4-->
<div><span>Mean serum ziprasidone concentrations by treatment group
(ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine
▴).</span></div>
</div>
</div>
<p id="__p24">The pharmacokinetic parameters for ziprasidone across
the three treatment groups were generally similar (<a href=
"/pmc/articles/PMC2015049/table/tbl2/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob=
"ob-tbl2" co-legend-rid=""><span>Table 2</span></a>). Individual
AUC(0, ∞) and <em>C</em><sub>max</sub> values are shown in <a href=
"/pmc/articles/PMC2015049/figure/fig02/" target="figure" class=
"fig-table-link fig figpopup" rid-figpopup="fig02" rid-ob=
"ob-fig02" co-legend-rid="lgnd_fig02"><span>Figures 2</span></a>
and <a href="/pmc/articles/PMC2015049/figure/fig03/" target=
"figure" class="fig-table-link fig figpopup" rid-figpopup="fig03"
rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span style=
"position: relative;text-decoration:none;">​<span class=
"figpopup-sensitive-area" style=
"left: -1.5em;">and3.</span></span><span>3</span></a>. The only
statistically significant difference between the treatment groups,
for any of the pharmacokinetic parameters, occurred in the
comparison of mean AUC(0, ∞) values in the ziprasidone + cimetidine
group with the ziprasidone alone group. This parameter was 6.2%
greater in the ziprasidone + cimetidine group than in the
ziprasidone alone group (95% CI: 100.6,113.5). None of the
differences in <em>C</em><sub>max</sub>,
<em>t</em><sub>max</sub>and λ<sub>z</sub> between the ziprasidone +
cimetidine group and the ziprasidone alone group was statistically
significant. The <em>t</em><sub>½,z</sub> of ziprasidone in the
ziprasidone + cimetidine group was 3.1% longer than that in the
ziprasidone alone group.</p>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl2"><a href="/pmc/articles/PMC2015049/table/tbl2/" target=
"table" rid-ob="ob-tbl2" rid-figpopup="tbl2" class=
"table img_link icnblk_img figpopup"><img alt="Table 2" title=
"Table 2" class="small-thumb" src=
"/pmc/articles/PMC2015049/table/tbl2/?report=thumb" src-large=
"/pmc/articles/PMC2015049/table/tbl2/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015049/table/tbl2/" target="table" rid-figpopup=
"tbl2" rid-ob="ob-tbl2">Table 2</a></div>
<!--caption a4-->
<div><span>Summary of pharmacokinetic parameters of
ziprasidone.</span></div>
</div>
</div>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig02"
co-legend-rid="lgnd_fig02"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015049/figure/fig02/" target="figure"
rid-figpopup="fig02" rid-ob="ob-fig02"><img src=
"/pmc/articles/PMC2015049/bin/bcp0049-057S-f2.gif" class=
"small-thumb" alt="Figure 2" title="Figure 2" src-large=
"/pmc/articles/PMC2015049/bin/bcp0049-057S-f2.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig02">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015049/figure/fig02/" target="figure"
rid-figpopup="fig02" rid-ob="ob-fig02">Figure 2</a></div>
<!--caption a4-->
<div><span>Individual AUC(0,∞) values by treatment group
(ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone + cimetidine
▴). Group means are shown as horizontal dashed lines.</span></div>
</div>
</div>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig03"
co-legend-rid="lgnd_fig03"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015049/figure/fig03/" target="figure"
rid-figpopup="fig03" rid-ob="ob-fig03"><img src=
"/pmc/articles/PMC2015049/bin/bcp0049-057S-f3.gif" class=
"small-thumb" alt="Figure 3" title="Figure 3" src-large=
"/pmc/articles/PMC2015049/bin/bcp0049-057S-f3.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig03">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015049/figure/fig03/" target="figure"
rid-figpopup="fig03" rid-ob="ob-fig03">Figure 3</a></div>
<!--caption a4-->
<div><span>Individual <em>C</em><sub>max</sub> values by treatment
group (ziprasidone ◊; ziprasidone + Maalox®▪; ziprasidone +
cimetidine ▴). Group means are shown as horizontal dashed
lines.</span></div>
</div>
</div>
<p id="__p32" class="p p-last">The mean AUC(0,∞),
<em>C</em><sub>max</sub>, <em>t</em><sub>max</sub> and
λ<sub>z</sub> values in the ziprasidone + Maalox® group were not
significantly different from those in the ziprasidone alone group.
The <em>t</em><sub>½,z</sub> of ziprasidone in the ziprasidone +
Maalox® group was almost identical to that in the group receiving
ziprasidone alone.</p>
</div>
</div>
<div id="__sec15" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec15title">Discussion</h2>
<p id="__p33" class="p p-first">Findings from this study indicate
that concomitant administration of cimetidine produces a small
increase in systemic exposure to ziprasidone as measured by the
AUC(0,∞). Although this increase was statistically significant, it
was small (6%) and is not considered to be clinically meaningful.
None of the other pharmacokinetic parameters that were measured
showed any statistically or clinically significant differences
between the ziprasidone + cimetidine and ziprasidone alone groups.
Similarly, no statistically significant differences between the
ziprasidone + Maalox® and ziprasidone alone groups were observed
for any of the measured pharmacokinetic parameters. The delay in
reaching <em>C</em><sub>max</sub> is unlikely to be of clinical
relevance.</p>
<p id="__p34">The lack of clinically significant effects of
cimetidine on the pharmacokinetics of ziprasidone was observed
despite the fact that oxidative ziprasidone metabolism is primarily
mediated by CYP3A4 [<a href="#b2" rid="b2" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012244">2</a>]. As cimetidine is known to be a
non-specific inhibitor of CYP3A4 [<a href="#b4" rid="b4" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012240">4</a>], the findings of this study suggest that
ziprasidone could also be metabolized via alternative pathways. In
view of the <em>in vitro</em> activity of ziprasidone for the
inhibition of CYP3A4 [<a href="#b4" rid="b4" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012242">4</a>], however, a single dose of ziprasidone
would seem unlikely to inhibit this isoenzyme substantially <em>in
vivo</em>. Nevertheless, the modest increase in the AUC(0,∞) is in
accord with this hypothesis. Alternatively, ziprasidone may be
excreted unchanged to a greater degree than normal in the presence
of cimetidine.</p>
<p id="__p35" class="p p-last">In conclusion, the findings of this
study indicate that the administration of multiple doses of
cimetidine or of Maalox® do not exert any clinically significant
influence on the single-dose pharmacokinetics of ziprasidone 40
mg.</p>
</div>
<div id="__ref-listid1087561" class="tsec sec">
<h2 class="head no_bottom_margin" id="__ref-listid1087561title">
References</h2>
<div class="ref-list-sec sec" id="reference-list">
<div class="ref-cit-blk half_rhythm" id="b1">1. <span class=
"element-citation">Wilner KD, Tensfeldt TG, Baris B, et al. Single-
and multiple-dose pharmacokinetics of ziprasidone in healthy young
and elderly volunteers. <span><span class="ref-journal">Br J Clin
Pharmacol.</span> 2000;<span class="ref-vol">49</span>(Suppl.
1):15S–20S.</span> <span class="nowrap ref pmc">[<a class=
"int-reflink" href="/pmc/articles/PMC2015054/">PMC free
article</a>]</span> <span class="nowrap ref pubmed">[<a href=
"/pubmed/10771449" target="pmc_ext" ref=
"reftype=pubmed&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b2">2. <span class=
"element-citation">Prakesh C, Kamel A, Cui D, et al. Identification
of the major human liver cytochrome P450 isoform responsible for
the primary metabolites of ziprasidone and prediction of possible
drug interactions. <span><span class="ref-journal">Br J Clin
Pharmacol.</span> 2000;<span class="ref-vol">49</span>(Suppl.
1):35S–42S.</span> <span class="nowrap ref pmc">[<a class=
"int-reflink" href="/pmc/articles/PMC2015052/">PMC free
article</a>]</span> <span class="nowrap ref pubmed">[<a href=
"/pubmed/10771452" target="pmc_ext" ref=
"reftype=pubmed&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b3">3. <span class=
"element-citation">Lebel M, Proulx MJ, Allard S, et al. Influence
of a high fat breakfast on the absorption and pharmacokinetics of
CP-88,059, a new antipsychotic. <span><span class=
"ref-journal">Clin Invest Med.</span> 1993;<span class=
"ref-vol">16</span>:B18.</span> Abstract 117.</span></div>
<div class="ref-cit-blk half_rhythm" id="b4">4. <span class=
"element-citation">Knodell RG, Browne DG, Gwozdz GP, et al.
Differential inhibition of individual human liver cytochrome P450
by cimetidine. <span><span class=
"ref-journal">Gastroenterology.</span> 1991;<span class=
"ref-vol">101</span>:1680–1691.</span> <span class=
"nowrap ref pubmed">[<a href="/pubmed/1955133" target="pmc_ext"
ref="reftype=pubmed&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b5">5. <span class=
"element-citation">Metropolitan height and weight tables
<span><span class="ref-journal">Stat Bull Metrop Life Found.</span>
1983;<span class="ref-vol">64</span>:3–9.</span> <span class=
"nowrap ref pubmed">[<a href="/pubmed/6623350" target="pmc_ext"
ref="reftype=pubmed&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b6">6. <span class=
"element-citation">Janiszewski JS, Fouda HG, Cole RO. Development
and validation of a high-sensitivity assay for an antipsychotic
agent, CP-88,059, with solid-phase extraction and narrow-bore
high-performance liquid chromatography. <span><span class=
"ref-journal">J Chromatogr.</span> 1995;<span class=
"ref-vol">668</span>:133–139.</span> <span class=
"nowrap ref pubmed">[<a href="/pubmed/7550970" target="pmc_ext"
ref="reftype=pubmed&amp;article-id=2015049&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
</div>
</div>
</div>
<!--post-content-->
<hr class="whole_rhythm no_bottom_margin" />
<div class="courtesy-note no_margin small">Articles from
<span class="acknowledgment-journal-title">British Journal of
Clinical Pharmacology</span> are provided here courtesy of
<strong>British Pharmacological Society</strong></div>
</div>
</div>
<!-- Book content --></div>
<div id="rightcolumn" class="four_col col last">
<!-- Custom content above discovery portlets -->
<div class="col6"></div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi=
"http://www.w3.org/2001/XMLSchema-instance">
<div class="try-button"><a href=
"/pmc/articles/PMC2015049/?report=reader"><img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/3838809"
alt="PubReader format: click here to try" /></a></div>
<div class="format-menu">
<h2>Formats:</h2>
<ul>
<li class="selected">Article</li>
<li style="list-style: none">|</li>
<li><a href=
"/pmc/articles/PMC2015049/?report=reader">PubReader</a></li>
<li style="list-style: none">|</li>
<li class="epub-link"><a href="/pmc/articles/PMC2015049/epub/">ePub
(beta)</a></li>
<li style="list-style: none">|</li>
<li><a href="/pmc/articles/PMC2015049/pdf/bcp0049-057S.pdf">PDF
(108K)</a></li>
<li style="list-style: none">|</li>
<li><a href="#" data-citationid="PMC2015049" class=
"citationexporter ctxp">Citation</a></li>
</ul>
</div>
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi=
"http://www.w3.org/2001/XMLSchema-instance" class="share-buttons">
<h2>Share</h2>
<ul>
<li class="facebook"><a href=
"https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2015049%2F">
<img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/4047626"
alt="Share on Facebook" /> Facebook</a></li>
<li class="twitter"><a href=
"https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2015049%2F&amp;text=The%20pharmacokinetics%20of%20ziprasidone%20in%20healthy%20volunteers%20treated%20with%20cimetidine%20or%20antacid">
<img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/4047627"
alt="Share on Twitter" /> Twitter</a></li>
<li class="gplus"><a href=
"https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2015049%2F">
<img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/4047628"
alt="Share on Google Plus" /> Google+</a></li>
</ul>
</div>
<div id="ajax-portlets" data-pmid="10771455" data-aiid="2015049"
data-aid="2015049" data-iid="151586" data-domainid="279"
data-domain="brjclinpharm" data-accid="PMC2015049" data-md5=
"a89006ef942bac03376a02949163fd1a"></div>
<!-- Custom content below discovery portlets -->
<div class="col7"></div>
</div>
</div>
<!-- Custom content after all -->
<div class="col8"></div>
<div class="col9"></div>
<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js">
</script> <script>
<![CDATA[
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
]]>
</script>
<div id="body-link-poppers"></div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<div class="breadcrumbs">You are here: <span id=
"breadcrumb_text"><a href="/guide/">NCBI</a> &gt; <a href=
"http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt;
<a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central
(PMC)</a></span></div>
<a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target=
"_blank" href=
"/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-04-01T09:54:11-04:00&amp;Host=ptpmc201">Write
to the Help Desk</a></div>
<div class="footer" id="footer">
<div class="subfooter"></div>
<script type="text/javascript" src=
"/portal/portal3rc.fcgi/static/js/preloaderWidget.js">
</script>
<div id="external-disclaimer" class="offscreen_noflow">External
link. Please review our <a href=
"http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div>
<div id="ncbifooter" class="contact_info">
<div id="footer-contents-right">
<div id="nlm_thumb_logo"><a href="http://www.nlm.nih.gov" title=
"NLM">NLM</a></div>
<div id="nih_thumb_logo"><a href="http://www.nih.gov" title=
"NIH">NIH</a></div>
<div id="hhs_thumb_logo"><a href="http://www.dhhs.gov" title=
"DHHS">DHHS</a></div>
<div id="usagov_thumb_logo"><a href="http://www.usa.gov" title=
"USA.gov">USA.gov</a></div>
</div>
<div id="footer-contents-left"><a href=
"/About/disclaimer.html">Copyright</a> | <a href=
"/About/disclaimer.html#disclaimer">Disclaimer</a> | <a href=
"http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a>
| <a href="/guide/browsers/">Browsers</a> | <a href=
"http://www.nlm.nih.gov/accessibility.html">Accessibility</a> |
<a href="/About/glance/contact_info.html">Contact</a>
<p class="address vcard"><span class="url"><a class=
"fn url newdomain" href="http://www.ncbi.nlm.nih.gov">National
Center for Biotechnology Information</a>,</span> <span class=
"org url"><a href="http://www.nlm.nih.gov/">U.S. National Library
of Medicine</a></span> <span class="adr"><span class=
"street-address">8600 Rockville Pike</span>, <span class=
"locality">Bethesda</span> <span class="region">MD</span>,
<span class="postal-code">20894</span> <span class=
"country-name">USA</span></span></p>
</div>
</div>
<script type="text/javascript" src=
"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1">
</script> <script type="text/javascript" src=
"/portal/portal3rc.fcgi/static/js/hfjs2.js">
</script></div>
</div>
</div>
<!--/.page--></div>
<!--/.wrap--></div>
<!-- /.twelve_col --></div>
<!-- /.grid -->
 <!-- BESelector tab -->
 <noscript><img alt="statistics" src=
"/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=brjclinpharm&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2015049/&amp;ncbi_app=pmc" />
</noscript> <!-- usually for JS scripts at page bottom -->
 <!--<component id="PageFixtures" label="styles"></component>-->
 
<!-- F4FB67056FE7D821_0165SID /projects/PMC/PMCViewer@4.35 ptpmc201 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->
 <script type="text/javascript" src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/js/3879255/3728312/3818874/3821238/4064716/4072593/4064449/3921943/4070217/4065628.js"
snapshot="pmc">
</script>
</body>
</html>
